New Zones Report
2027 Pharma Lab Automation Benchmark
This comprehensive report provides original benchmark data on AI, robotics, and LIMS adoption across the industry, documenting where integration works, where it stalls, and what labs are prioritizing to stay competitive and compliant.

Who should read the report
Pharma QC and QA analytical lab decision-makers facing pressure to scale throughout and data integrity without expanding headcount or expenditure. R&D/analytical development scientists, lab and lab operations managers, CMC leads, CDMO analytical development managers
Key insights you'll gain
- ROI-Driven Automation
Learn which high-volume workflows (dissolution, content uniformity) deliver fastest payback from robotics, with documented cycle-time reductions of 75%.
- Biologics Toolkit Justification
Understand why Multi-Attribute Method (MAM) consolidates multiple QC tests, reducing solvent use while meeting FDA biosimilarity requirements.
Introduction
Setting the stage for transformation in Americas pharmaceutical manufacturing
Innovation, Resilience, and Strategy – the CPHI Americas Roundtable
Exclusive perspectives from industry thought leaders on building resilient supply chains and embracing collaborative ecosystems
Beyond the Stage: Conference Insights
Key takeaways from five dedicated content tracks covering R&D, sustainability, the LATAM pharma landscape, Women's Networking Event, and more
Start-Up Stories: Zymvol Biomodeling
Breakthrough innovations from emerging companies reshaping the pharmaceutical value chain
Sustainability in a Fragmented Global Economy
Practical strategies for environmental responsibility amid supply chain complexity and regulatory diversity
The Road to Miami 2027
Why Miami's emergence as a pharmaceutical hub matters for your business—from world-class logistics infrastructure to business-friendly environment and growing industry presence
Contributors
Meet the experts and organizations shaping the conversation
References
Supporting data and sources
Pharma QC and QA analytical lab decision-makers facing pressure to scale throughout and data integrity without expanding headcount or expenditure. R&D/analytical development scientists, lab and lab operations managers, CMC leads, CDMO analytical development managers
Dual-Return Investments
Discover how single systems satisfy both data integrity and sustainability audits, eliminating redundant compliance builds and maximising capital efficiency.
ROI-Driven Automation
Learn which high-volume workflows (dissolution, content uniformity) deliver fastest payback from robotics, with documented cycle-time reductions of 75%.
Biologics Toolkit Justification
Understand why Multi-Attribute Method (MAM) consolidates multiple QC tests, reducing solvent use while meeting FDA biosimilarity requirements.
Organisational Readiness Roadmap
Access frameworks for building real-time quality systems, resilient supply chains, and workforce capabilities—the true 2027 constraint on lab modernisation.
Download the 2027 Pharma Lab Automation Benchmark Report
New zone 2027: Lab & Analytical Equipment
A pharma focused space for the technologies shaping modern labs
A new dedicated pharma-focused zone for analytical instruments, lab automation and QC technologies. Connect directly with R&D, QA/QC and process development teams responsible for building smarter, more automated and more compliant pharmaceutical laboratories.
Frankfurt, Germany, 9-11 November 2027
New zone
Lab & Analytical Equipment
We're bringing laboratory innovation directly to the heart of pharma. The Lab & Analytical Equipment zone is a pharma-focussed area dedicated to chromatography, mass spectrometry, spectroscopy, lab automation, LIMS and QC testing technologies. Designed for teams specialising in R&D, QA and process development, this part of the show floor is all about driving laboratory innovation, developments and investments.
A $50–60B market underpinning the future of pharmaceutical laboratories
AI, automation and digital lab technologies are driving towards smarter, integrated labs
Pharma accounts for 20–30% of total lab-equipment demand
Lab & Analytical Equipment zone
Who you'll meet
Senior pharma lab buyers actively investing in lab modernisation:
R&D & Analytical Development
advancing methods, testing and drug development
QC & QA leaders
ensuring compliance, quality and data integrity
Laboratory Operations Managers
investing in smarter, more automated workflows
Process-development & CMC Teams
improving precision across the product lifecycle
CDMO & Biotech Decision-Makers
sourcing scalable and integrated laboratory technologies
CPHI in numbers
Europe's largest pharmaceutical event
Exhibit
Secure your founding exhibitor position in the Lab & Analytical Equipment zone at CPHI Frankfurt 2027 and help define the future of pharma laboratory innovation and analytical science.
Attend
Experience CPHI Frankfurt 2027 first-hand before joining the founding cohort of the Lab & Analytical Equipment zone.
